Fineline Cube

Follow:
14748 Articles
CompanyDrug

Huadong Medicine’s Arcalyst (Rilonacept) Filing for CAPSs Accepted by China’s NMPA

CompanyDrug

Jiangsu Hengrui Pharmaceuticals’ HR20031 Accepted for Review by China’s NMPA for Type 2 Diabetes

CompanyDrug

AstraZeneca’s Imfinzi Gains NMPA Approval for First-Line Cholangiocarcinoma Treatment

CompanyDrug

Hansoh Pharmaceutical’s HS-10511 Tablets for Hypertrophic Cardiomyopathy Cleared for Clinical Trials

CompanyDeals

Chiesi Farmaceutici and Shanghai Pharmaceutical Partner on Distribution at CIIE

CompanyDeals

Bayer Shifts Focus of Recursion Pharmaceuticals Collaboration to Precision Oncology

CompanyDeals

Lizhu Pharmaceutical Cancels ChiNext IPO, Opts for NEEQ Listing for Subsidiary Lizhu Reagent

CompanyDrug

Novo Nordisk Commits Over DKK 42 Billion to Expand Chronic Disease Production in Denmark

Company

Eli Lilly China’s President Benjamin L. Basil to Depart for Personal Reasons

CompanyDrug

Clinical Research on rAAV Gene Drug ZS805 for Fabry Disease Launched by Zhishan Weixin

CompanyDrug

Jiangsu Hengrui Pharmaceuticals’ Subsidiary Shengdi Pharmaceuticals Receives NMPA Approval for HRS-9057

CompanyDrug

Beijing Aosaikang’s Combo Therapy for NSCLC Accepted for Clinical Trial by NMPA